We announced our full year and fourth quarter 2017 results on Wednesday 7 February.
Today, we announced our FY 2017 results. GSK delivered encouraging results from across the Company with sales growth in each of our 3 global businesses
, an improved Group operating margin, Adjusted EPS growth of 4% (CER) and stronger free cash flow. 
See full results: http://gsk.to/2E1jP6V
No comments:
Post a Comment